{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:33:03Z","timestamp":1793759583529,"version":"4.6.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,15]],"date-time":"2023-07-15T00:00:00Z","timestamp":1689379200000},"content-version":"am","delay-in-days":348,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jhep.2022.02.023","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T11:19:17Z","timestamp":1646392757000},"page":"424-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Deleting the \u03b2-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth"],"prefix":"10.1016","volume":"77","author":[{"given":"Robin","family":"Loesch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Paradis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Godard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e9lique","family":"Gougelet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Renault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9076-3081","authenticated-orcid":false,"given":"Simon","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoan","family":"Renoux-Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Perret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto Mark","family":"Taketo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5687-0334","authenticated-orcid":false,"given":"Jessica","family":"Zucman-Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3949-9107","authenticated-orcid":false,"given":"Sabine","family":"Colnot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2022.02.023_bib1","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.jhep.2019.06.001","article-title":"Molecular and histological correlations in liver cancer","volume":"71","author":"Calderaro","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.02.023_bib2","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1073\/pnas.95.15.8847","article-title":"Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas","volume":"95","author":"de La Coste","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2022.02.023_bib3","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/hep.26924","article-title":"T-cell factor 4 and beta-catenin chromatin occupancies pattern zonal liver metabolism in mice","volume":"59","author":"Gougelet","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.02.023_bib4","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/hep.28638","article-title":"Genotype-phenotype correlation of CTNNB1 mutations reveals different ss-catenin activity associated with liver tumor progression","volume":"64","author":"Rebouissou","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.02.023_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2022.02.023_bib6","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jhep.2017.12.018","article-title":"AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of beta-catenin activation","volume":"68","author":"Abitbol","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.02.023_bib7","doi-asserted-by":"crossref","first-page":"17216","DOI":"10.1073\/pnas.0404761101","article-title":"Liver-targeted disruption of Apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas","volume":"101","author":"Colnot","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2022.02.023_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/35094067","article-title":"APC, signal transduction and genetic instability in colorectal cancer","volume":"1","author":"Fodde","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jhep.2022.02.023_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.biocel.2009.07.012","article-title":"Wnt signaling and hepatocarcinogenesis: the hepatoblastoma model","volume":"43","author":"Armengol","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.jhep.2022.02.023_bib10","first-page":"1971","article-title":"Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin","volume":"62","author":"Harada","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2022.02.023_bib11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.devcel.2006.03.015","article-title":"Apc tumor suppressor gene is the \"zonation-keeper\" of mouse liver","volume":"10","author":"Benhamouche","year":"2006","journal-title":"Dev Cell"},{"key":"10.1016\/j.jhep.2022.02.023_bib12","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1136\/gutjnl-2014-308969","article-title":"Antitumour activity of an inhibitor of miR-34a in liver cancer with beta-catenin-mutations","volume":"65","author":"Gougelet","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.02.023_bib13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1053\/j.gastro.2019.05.069","article-title":"Hepatocellular carcinomas with mutational activation of beta-catenin require choline and can Be detected by positron emission tomography","volume":"157","author":"Gougelet","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.02.023_bib14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","article-title":"In\u00a0vivo genome editing using Staphylococcus aureus Cas9","volume":"520","author":"Ran","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2022.02.023_bib15","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1053\/jhep.2002.33164","article-title":"A\u00a0tamoxifen-inducible chimeric Cre recombinase specifically effective in the fetal and adult mouse liver","volume":"35","author":"Tannour-Louet","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.02.023_bib16","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-20-1809","article-title":"Integrated genomic analysis identifies driver genes and cisplatin-resistant progenitor phenotype in pediatric liver cancer","author":"Hirsch","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jhep.2022.02.023_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/hep.21467","article-title":"Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets","volume":"45","author":"Boyault","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.02.023_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","article-title":"Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification","volume":"67","author":"Calderaro","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.02.023_bib19","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hep.21952","article-title":"Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate","volume":"47","author":"Decaens","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2022.02.023_bib20","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1053\/j.gastro.2014.07.026","article-title":"Hippo\/YAP, beta-catenin, and the cancer cell: a \"menage a trois\" in hepatoblastoma","volume":"147","author":"Sylvester","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.02.023_bib21","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.05.004","article-title":"Activation of beta catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice","author":"Tao","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2022.02.023_bib22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.cell.2011.09.048","article-title":"The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells","volume":"147","author":"Cordenonsi","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2022.02.023_bib23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1158\/0008-5472.CAN-03-2123","article-title":"Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations","volume":"64","author":"Harada","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2022.02.023_bib24","doi-asserted-by":"crossref","first-page":"14771","DOI":"10.1073\/pnas.0706578104","article-title":"Distinct pathways of genomic progression to benign and malignant tumors of the liver","volume":"104","author":"Tward","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2022.02.023_bib25","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1158\/0008-5472.CAN-10-2705","article-title":"Coactivation of AKT and beta-catenin in mice rapidly induces formation of lipogenic liver tumors","volume":"71","author":"Stauffer","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2022.02.023_bib26","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/gutjnl-2017-315448","article-title":"beta-catenin-activated hepatocellular carcinomas are addicted to fatty acids","volume":"68","author":"Senni","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.02.023_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2010.10.021","article-title":"The transforming growth factor-alpha and cyclin D1 genes are direct targets of beta-catenin signaling in hepatocyte proliferation","volume":"55","author":"Torre","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jhep.2022.02.023_bib28","doi-asserted-by":"crossref","first-page":"816125","DOI":"10.1155\/2012\/816125","article-title":"A\u00a0complex interplay between wnt\/beta-catenin signalling and the cell cycle in the adult liver","volume":"2012","author":"Gougelet","year":"2012","journal-title":"Int J Hepatol"},{"key":"10.1016\/j.jhep.2022.02.023_bib29","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1158\/0008-5472.CAN-13-3275","article-title":"beta-catenin activation in a novel liver progenitor cell type is sufficient to cause hepatocellular carcinoma and hepatoblastoma","volume":"74","author":"Mokkapati","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2022.02.023_bib30","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1172\/JCI77995","article-title":"Hepatocellular carcinoma originates from hepatocytes and not from the progenitor\/biliary compartment","volume":"125","author":"Mu","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jhep.2022.02.023_bib31","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.celrep.2014.07.003","article-title":"Evidence against a stem cell origin of new hepatocytes in a common mouse model of chronic liver injury","volume":"8","author":"Schaub","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2022.02.023_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.stem.2014.09.008","article-title":"Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes","volume":"15","author":"Tarlow","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jhep.2022.02.023_bib33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.stem.2014.06.003","article-title":"Adult hepatocytes are generated by self-duplication rather than stem cell differentiation","volume":"15","author":"Yanger","year":"2014","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jhep.2022.02.023_bib34","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.tibs.2020.08.012","article-title":"YAP and TAZ are not identical twins","volume":"46","author":"Reggiani","year":"2021","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.jhep.2022.02.023_bib35","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.celrep.2015.02.027","article-title":"YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression","volume":"10","author":"Fitamant","year":"2015","journal-title":"Cell Rep"},{"key":"10.1016\/j.jhep.2022.02.023_bib36","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.ymthe.2020.04.017","article-title":"AAV-CRISPR gene editing is negated by pre-existing immunity to Cas9","volume":"28","author":"Li","year":"2020","journal-title":"Mol Ther"},{"key":"10.1016\/j.jhep.2022.02.023_bib37","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/gutjnl-2019-318281","article-title":"Adeno-associated virus in the liver: natural history and consequences in tumour development","volume":"69","author":"La Bella","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2022.02.023_bib38","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ng.3389","article-title":"Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas","volume":"47","author":"Nault","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2022.02.023_bib39","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1038\/s41467-019-12449-2","article-title":"High levels of AAV vector integration into CRISPR-induced DNA breaks","volume":"10","author":"Hanlon","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jhep.2022.02.023_bib40","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40259-017-0234-5","article-title":"Adeno-associated\u00a0virus\u00a0(AAV) as a vector for gene therapy","volume":"31","author":"Naso","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.jhep.2022.02.023_bib41","article-title":"Potentials of CRISPR in liver research and therapy","author":"Loesch","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822001301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822001301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:44:33Z","timestamp":1759175073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827822001301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S0168827822001301"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2022.02.023","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deleting the \u03b2-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2022.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}